Caption
Stem Cell Research
Targeting different brain cells could be an option for new Parkinson’s treatments
Date
News
Date
A new study aims to understand insulin resistance in people with Parkinson’s, and how this could inform future drug trials of existing diabetes treatments.
Date
Researchers and experts from around the world gathered in Phoenix, Arizona last month to discuss the very latest in Parkinson’s research. Our Associate Director of Research, Claire Bale, reports back on the most exciting developments and what we might see next.
Date
Researchers have discovered that changes in a gene cause a range of neurological conditions that involve a loss of brain cells, including Parkinson’s.
Date
We’re working with EndLyz Therapeutics to fund the development of 2 potential drugs that could clear cells of unwanted materials that contribute to the causes of Parkinson’s.
Date
A study, part-funded by Parkinson’s UK, has uncovered important insights into why some people with Parkinson’s develop dementia, while others don’t.
Date
New research shows changes to microbes in the gut can be detected before Parkinson’s symptoms appear.
Date
The therapy has been given conditional, limited approval for people in Japan based on the results of a 2-year research study.
Date
A £1.7 million partnership will combine data from over 20,000 people to accelerate the search for new treatments for Parkinson’s.
Date
This International Women’s Day, we're celebrating 3 remarkable women making a real difference for people with Parkinson’s. Reflecting the theme Give to Gain, their leadership, skills and passion help the Parkinson’s community thrive.
Date
Herantis Pharma Plc to receive almost £7 million from the European Union for a phase 2 trial of HER-096 that has the potential to slow or stop Parkinson’s.